Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Trinity Bio ADR (TRIB)

Trinity Bio ADR (TRIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,310
  • Shares Outstanding, K 3,592
  • Annual Sales, $ 61,560 K
  • Annual Income, $ -31,790 K
  • EBIT $ -25 M
  • EBITDA $ -23 M
  • 60-Month Beta N/A
  • Price/Sales 0.39
  • Price/Cash Flow N/A
  • Price/Book N/A

Options Overview Details

View History
  • Implied Volatility 422.76% (-40.82%)
  • Historical Volatility 72.29%
  • IV Percentile 45%
  • IV Rank 27.40%
  • IV High 1,404.48% on 11/19/25
  • IV Low 52.22% on 09/04/25
  • Expected Move (DTE 9) 1.3685 (121.11%)
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 8
  • Put/Call OI Ratio 0.21
  • Today's Open Interest 1,248
  • Open Int (30-Day) 1,505
  • Expected Range 0.0000 to 2.4985

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/25
See More
  • Average Estimate -1.48
  • Number of Estimates 1
  • High Estimate -1.48
  • Low Estimate -1.48
  • Prior Year -2.15
  • Growth Rate Est. (year over year) +31.16%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7980 +42.23%
on 11/18/25
1.2200 -6.97%
on 12/09/25
+0.1948 (+20.72%)
since 11/10/25
3-Month
0.7980 +42.23%
on 11/18/25
1.2768 -11.11%
on 09/11/25
-0.0250 (-2.16%)
since 09/10/25
52-Week
0.4800 +136.46%
on 04/07/25
3.4400 -67.01%
on 08/14/25
+0.3417 (+43.07%)
since 12/10/24

Most Recent Stories

More News
Global Drug Screening Market Is Forecasted to Reach $19.5 Billion By 2029

EQNX::TICKER_START (NASDAQ:INBS),(NASDAQ:CDIO),(NASDAQ:BIAF),(NASDAQ:TRIB),(NASDAQ:SOBR) EQNX::TICKER_END

TRIB : 1.1390 (-5.08%)
BIAF : 1.6800 (+1.20%)
INBS : 0.7324 (-1.07%)
CDIO : 3.71 (-3.64%)
SOBR : 1.8800 (-4.08%)
TRIB, SLXN, STSS: Why Retail Chatter On 3 Nano-Cap Healthcare Stocks Exploded Over 6000%

“Compelling” results from a study, promising pre-clinical data and a public offering got Stocktwits investors buzzing on Tuesday.

TRIB : 1.1390 (-5.08%)
STSS : 2.79 (-2.45%)
SLXN : 2.96 (-3.27%)
Trinity Biotech plc Announces WHO Approval for Manufacturing Transfer of HIV Tests as Part of Comprehensive Transformation Plan

Trinity Biotech updates on its transformation plan, announcing WHO approval for offshore HIV test manufacturing, enhancing growth potential.Quiver AI SummaryTrinity Biotech plc, a biotechnology company...

TRIB : 1.1390 (-5.08%)
Trinity Biotech plc Reports Q3 2024 Revenue Growth of 3% to $15.2 Million, Driven by Strong TrinScreen HIV Product Demand

Trinity Biotech reported Q3 2024 revenue of $15.2 million, with a 3% year-over-year increase and strong Point-of-Care sales.Quiver AI SummaryTrinity Biotech plc reported a 3% year-on-year revenue growth...

TRIB : 1.1390 (-5.08%)
Trinity Biotech Announces Quarter 1 2022 Financial Results

DUBLIN, Ireland, June 30, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.1390 (-5.08%)
Trinity Biotech plc to Announce First Quarter Fiscal Year 2022 Financial Results

Conference Call Scheduled for June 30, 2022 at 11:00 am EASTERN...

TRIB : 1.1390 (-5.08%)
Trinity Biotech Announces CE Mark of its 10-Minute Covid-19 Antigen Test

DUBLIN, Ireland, May 20, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB) has achieved a CE Mark for its 10-minute Covid-19 antigen test. This...

TRIB : 1.1390 (-5.08%)
Trinity Biotech Announces the Successful Closing of its Strategic Investment and Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, May 03, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the...

TRIB : 1.1390 (-5.08%)
Trinity Biotech Announces Quarter 4 and Fiscal Year 2021 Financial Results

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for...

TRIB : 1.1390 (-5.08%)
Trinity Biotech Announces A $45 Million Strategic Investment And Partnership With The MiCo Group of South Korea

DUBLIN, Ireland, April 11, 2022 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq: TRIB), a leading global diagnostic company (“Trinity Biotech” or the...

TRIB : 1.1390 (-5.08%)

Business Summary

Trinity Biotech plc, headquartered in Bray, the Republic of Ireland, develops, acquires, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market worldwide. The company provides two haemostasis product lines, Biopool and...

See More

Key Turning Points

3rd Resistance Point 1.3733
2nd Resistance Point 1.2967
1st Resistance Point 1.2483
Last Price 1.1390
1st Support Level 1.1233
2nd Support Level 1.0467
3rd Support Level 0.9983

See More

52-Week High 3.4400
Fibonacci 61.8% 2.3093
Fibonacci 50% 1.9600
Fibonacci 38.2% 1.6107
Last Price 1.1390
52-Week Low 0.4800

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar